Agilent Shares Up 8 Percent on Strong Growth in Q3 Revenue, Profit | GenomeWeb
NEW YORK (GenomeWeb News) – Shares in Agilent were up 8.14 percent, or $2.32, at $30.79 in mid-afternoon trading after the company yesterday reported a surge in third-quarter revenue and profit.
 
As GenomeWeb News reported this morning, Agilent said total revenues for the three months ended June 30 increased 17 percent to $1.45 billion from $1.24 billion in the same quarter last year. The company’s net income rose 118 percent to $227 million from $104 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.